REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction
Clinical trial NCT06237309 · TERMINATED
Trial details
- NCT number
- NCT06237309
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-11
- Primary completion
- 2025-09-17
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.